首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Complement Factor H Limits Immune Complex Deposition and Prevents Inflammation and Scarring in Glomeruli of Mice with Chronic Serum Sickness
【24h】

Complement Factor H Limits Immune Complex Deposition and Prevents Inflammation and Scarring in Glomeruli of Mice with Chronic Serum Sickness

机译:补体因子H限制了免疫复合物的沉积,并预防了患有慢性血清病的小鼠肾小球的炎症和瘢痕形成

获取原文
           

摘要

Factor H is the major complement regulator in plasma. Abnormalities in factor H have been implicated in membranoproliferative glomerulonephritis in both humans and experimental animals. It has been shown that factor H on rodent platelets functions analogously to human erythrocyte complement receptor 1 in its role to traffic immune complexes to the mononuclear phagocyte system. C57BL/6 factor H-deficient mice (Cfha?’/a?’) and wild-type (wt) controls were immunized daily for 5 wk with heterologous apoferritin to study the chronic serum sickness GN model. Immunizations were started in 6- to 8-wk-old mice, which was before the development of spontaneous membranoproliferative glomerulonephritis in some Cfha?’/a?’ animals. Glomerular deposition of IgG immune complexes in glomeruli was qualitatively and quantitatively increased in Cfha?’/a?’ mice compared with wt mice. Consistent with the increase in glomerular immune complexes and possibly because of alternative pathway complement activation, Cfha?’/a?’ mice had increased glomerular C3 deposition. Wt mice developed no glomerular pathology. In contrast, Cfha?’/a?’ mice developed diffuse proliferative GN with focal crescents and glomerulosclerosis. In addition, there was significantly increased expression of collagen IV, fibronectin, and laminin mRNA in Cfha?’/a?’ glomeruli. These data show a role for platelet-associated factor H to process immune complexes and limit their accumulation in glomeruli. Once deposited in glomeruli, excessive complement activation can lead to glomerular inflammation and the rapid development of a scarring phenotype.
机译:因子H是血浆中主要的补体调节因子。人类和实验动物的膜增生性肾小球肾炎均与H因子异常有关。已经表明,啮齿动物血小板上的因子H在将免疫复合物运输到单核吞噬细胞系统中的作用类似于人红细胞补体受体1。每天用异源载铁蛋白对小鼠的C57BL / 6因子H缺陷型小鼠(Cfha?/ a?)和野生型(wt)对照免疫5周,以研究慢性血清病GN模型。在6至8周龄的小鼠中开始免疫,这是在某些Cfha / a'动物中自发性膜增生性肾小球肾炎发生之前。与wt小鼠相比,Cfha / a / a小鼠的IgG免疫复合物在肾小球中的肾小球定性和定量增加。与肾小球免疫复合物增加以及可能由于替代途径补体激活相一致,Cfha?/ a?'小鼠肾小球C3沉积增加。 Wt小鼠没有肾小球病理。相比之下,Cfha?/ a?'小鼠发展为弥漫性增殖性GN,伴有局灶性新月和肾小球硬化。此外,在Cfha?/ a?肾小球中,胶原IV,纤连蛋白和层粘连蛋白mRNA的表达显着增加。这些数据表明血小板相关因子H可以处理免疫复合物并限制其在肾小球中的积累。一旦沉积在肾小球中,过度的补体激活会导致肾小球发炎和瘢痕表型的迅速发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号